166 related articles for article (PubMed ID: 37326491)
1. Brief Communication: Lambert-Eaton Myasthenic Paraneoplastic Syndrome Associated With Merkel Cell Carcinoma Successfully Treated by Immune Checkpoint Inhibitors: 2 Cases.
Gra M; Pham-Ledard A; Gerard E; Dutriaux C; Beylot-Barry M; Duval F; Carla L; Soulages A; Prey S
J Immunother; 2023 Sep; 46(7):276-278. PubMed ID: 37326491
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma.
Dohrn MF; Schöne U; Küppers C; Christen D; Schulz JB; Gess B; Tauber S
Neurol Res Pract; 2020; 2():52. PubMed ID: 33324947
[TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome and merkel cell carcinoma.
Nguyen ND; Simmons DB; Bersabe AR; Duginski TM; Sladky JH; Walton D; Will M; Renshaw JS
Cutis; 2019 May; 103(5):E19-E23. PubMed ID: 31233589
[TBL] [Abstract][Full Text] [Related]
4. Surgery results in complete cure of Lambert-Eaton myasthenic syndrome in a patient with metastatic Merkel cell carcinoma.
Siau RT; Morris A; Karoo RO
J Plast Reconstr Aesthet Surg; 2014 Jun; 67(6):e162-4. PubMed ID: 24704152
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic and metastatic neurologic complications of Merkel cell carcinoma.
Eggers SD; Salomao DR; Dinapoli RP; Vernino S
Mayo Clin Proc; 2001 Mar; 76(3):327-30. PubMed ID: 11243282
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert-Eaton myasthenic syndrome: A case report.
Green C; Isaksson Mettävainio M; Kjellman C; Ramqvist T; Dalianis T; Israelsson P; Lindquist D
Oncol Lett; 2022 Nov; 24(5):393. PubMed ID: 36276497
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
8. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.
Clouston PD; Saper CB; Arbizu T; Johnston I; Lang B; Newsom-Davis J; Posner JB
Neurology; 1992 Oct; 42(10):1944-50. PubMed ID: 1407577
[TBL] [Abstract][Full Text] [Related]
10. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
11. Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome.
Machiyama H; Minami S
J Med Cases; 2023 Feb; 14(2):71-75. PubMed ID: 36896371
[TBL] [Abstract][Full Text] [Related]
12. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
13. [Lambert-Eaton myasthenic syndrome--a rare manifestation of paraneoplastic syndrome in ovarian cancer--case report].
Zivaljević M; Popović S; Vujkov T
Med Pregl; 2005; 58(9-10):495-7. PubMed ID: 16526254
[TBL] [Abstract][Full Text] [Related]
14. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations.
Iyer JG; Parvathaneni K; Bhatia S; Tarabadkar ES; Blom A; Doumani R; McKenzie J; Asgari MM; Nghiem P
J Am Acad Dermatol; 2016 Sep; 75(3):541-547. PubMed ID: 27177440
[TBL] [Abstract][Full Text] [Related]
16. Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report.
Agostini A; Merli M; Avallone G; Burzi L; Mastorino L; Parisi M; Bertuzzo D; Ferrero B; Cerrato M; Badellino S; Molinaro L; Lopiano L; Ribero S; Quaglino P
Acta Derm Venereol; 2021 May; 101(5):adv00452. PubMed ID: 33846760
[No Abstract] [Full Text] [Related]
17. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Lambert-Eaton myasthenic syndrome: a diagnostic challenge.
Viveiros L; Martins SR; Pires SX; Neves J
BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36707096
[TBL] [Abstract][Full Text] [Related]
19. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
20. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
